Hereditary Angioedema Therapeutics Market, By Drug Class (C1-Esterase Inhibitors, Plasma Kallikrein Inhibitors, Bradykinin B2 Receptor Antagonists, Factor XIIa Inhibitors, RNA-Targeted Therapies and Others), By Treatment Type, By Route of Administration, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033

TABLE OF CONTENTS
1. Hereditary Angioedema Therapeutics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. Hereditary Angioedema Therapeutics Key Market Trends
3.1. Hereditary Angioedema Therapeutics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Hereditary Angioedema Therapeutics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Hereditary Angioedema Therapeutics Market Opportunities
3.4. Hereditary Angioedema Therapeutics Market Future Trends
4. Hereditary Angioedema Therapeutics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Hereditary Angioedema Therapeutics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Hereditary Angioedema Therapeutics Market Landscape
6.1. Hereditary Angioedema Therapeutics Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Hereditary Angioedema Therapeutics Market – By Drug Class
7.1. Overview
7.1.1. Segment Share Analysis, By Drug Class, 2025 & 2033 (%)
7.1.2. C1-Esterase Inhibitors
7.1.3. Plasma Kallikrein Inhibitors
7.1.4. Bradykinin B2 Receptor Antagonists
7.1.5. Factor XIIa Inhibitors
7.1.6. RNA-Targeted Therapies
7.1.7. Others
8. Hereditary Angioedema Therapeutics Market – By Treatment Type
8.1. Overview
8.1.1. Segment Share Analysis, By Treatment Type, 2025 & 2033 (%)
8.1.2. On-Demand Treatment
8.1.3. Prophylaxis Treatment
9. Hereditary Angioedema Therapeutics Market – By Route of Administration
9.1. Overview
9.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
9.1.2. Intravenous
9.1.3. Subcutaneous
9.1.4. Oral
10. Hereditary Angioedema Therapeutics Market – By End User
10.1. Overview
10.1.1. Segment Share Analysis, By Treatment Type, 2025 & 2033 (%)
10.1.2. Hospitals
10.1.3. Specialty Clinics
10.1.4. Home Healthcare
10.1.5. Others
11. Hereditary Angioedema Therapeutics Market– By Geography
11.1. Introduction
11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
11.2. North America
11.2.1. Overview
11.2.2. Hereditary Angioedema Therapeutics Key Manufacturers in North America
11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.2.4. North America Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.2.5. North America Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.2.6. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.7. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.8. U.S.
11.2.8.1. Overview
11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.2.8.4. U.S. Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.2.8.5. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.8.6. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.2.9. Canada
11.2.9.1. Overview
11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.2.9.4. Canada Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.2.9.5. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.2.9.6. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3. Europe
11.3.1. Overview
11.3.2. Hereditary Angioedema Therapeutics Key Manufacturers in Europe
11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.3.4. Europe Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.5. Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.6. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.7. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.8. Germany
11.3.8.1. Overview
11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.8.4. Germany Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.8.5. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.8.6. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.9. UK
11.3.9.1. Overview
11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.9.3. UK Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.9.4. UK Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.9.5. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.9.6. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.10. France
11.3.10.1. Overview
11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.10.3. France Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.10.4. France Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.10.5. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.10.6. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.11. Italy
11.3.11.1. Overview
11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.11.3. Italy Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.11.4. Italy Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.11.5. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.11.6. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.12. Spain
11.3.12.1. Overview
11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.12.3. Spain Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.12.4. Spain Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.12.5. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.12.6. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.13. The Netherlands
11.3.13.1. Overview
11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.13.3. The Netherlands Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.13.4. The Netherlands Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.13.5. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.14. Sweden
11.3.14.1. Overview
11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.14.3. Sweden Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.14.4. Sweden Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.14.5. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.14.6. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.15. Russia
11.3.15.1. Overview
11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.15.3. Russia Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.15.4. Russia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.15.5. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.15.6. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.16. Poland
11.3.16.1. Overview
11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.16.3. Poland Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.16.4. Poland Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.16.5. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.16.6. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.17. Denmark
11.3.17.1. Overview
11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.17.3. Poland Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.17.4. Denmark Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.17.5. Denmark Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.17.6. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.3.18. Rest of Europe
11.3.18.1. Overview
11.3.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.3.18.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.3.18.4. Rest of the Europe Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.3.18.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.3.18.6. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4. Asia Pacific (APAC)
11.4.1. Overview
11.4.2. Hereditary Angioedema Therapeutics Key Manufacturers in Asia Pacific
11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.4.4. APAC Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.5. APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.6. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.7. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.8. China
11.4.8.1. Overview
11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.8.3. China Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.8.4. China Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.8.5. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.8.6. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.9. India
11.4.9.1. Overview
11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.9.3. India Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.9.4. India Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.9.5. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.9.6. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.10. Japan
11.4.10.1. Overview
11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.10.4. Japan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.10.5. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.10.6. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.11. South Korea
11.4.11.1. Overview
11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.11.4. South Korea Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.11.5. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.11.6. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.12. Australia
11.4.12.1. Overview
11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.12.4. Australia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.12.5. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.12.6. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.13. Indonesia
11.4.13.1. Overview
11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.13.3. Indonesia Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.13.4. Indonesia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.13.6. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.14. Thailand
11.4.14.1. Overview
11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.14.3. Thailand Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.14.4. Thailand Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.14.5. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.14.6. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.15. Philippines
11.4.15.1. Overview
11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.15.4. Philippines Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.15.5. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.15.6. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.16. Taiwan
11.4.16.1. Overview
11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.16.3. Taiwan Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.16.4. Taiwan Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.16.5. Taiwan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.16.6. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.17. Vietnam
11.4.17.1. Overview
11.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.17.3. Vietnam Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.17.4. Vietnam Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.17.5. Vietnam Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.17.6. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.4.18. Rest of APAC
11.4.18.1. Overview
11.4.18.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.4.18.3. Rest of APAC Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.4.18.4. Rest of APAC Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.4.18.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.4.18.6. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5. Latin America (LATAM)
11.5.1. Overview
11.5.2. Hereditary Angioedema Therapeutics Key Manufacturers in Latin America
11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.5.4. LATAM Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.5. LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.6. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.7. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.8. Brazil
11.5.8.1. Overview
11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.8.4. Brazil Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.8.5. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.8.6. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.9. Mexico
11.5.9.1. Overview
11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.9.4. Mexico Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.9.5. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.9.6. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.10. Argentina
11.5.10.1. Overview
11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.10.4. Argentina Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.10.5. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.10.6. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.11. Colombia
11.5.11.1. Overview
11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.11.4. Colombia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.11.5. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.11.6. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.5.12. Rest of LATAM
11.5.12.1. Overview
11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.5.12.4. Rest of LATAM Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.5.12.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6. Middle East and Africa (MEA)
11.6.1. Overview
11.6.2. Hereditary Angioedema Therapeutics Key Manufacturers in Middle East and Africa
11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
11.6.4. MEA Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.5. MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.6. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.7. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.8. Saudi Arabia
11.6.8.1. Overview
11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.8.4. Saudi Arabia Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.8.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.9. United Arab Emirates
11.6.9.1. Overview
11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.9.4. United Arab Emirates Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.9.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.10. Israel
11.6.10.1. Overview
11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.10.4. Israel Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.10.5. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.10.6. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.11. Turkey
11.6.11.1. Overview
11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.11.4. Turkey Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.11.5. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.11.6. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.12. Algeria
11.6.12.1. Overview
11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.12.4. Algeria Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.12.5. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.12.6. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.13. Egypt
11.6.13.1. Overview
11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.13.4. Egypt Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.13.5. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.13.6. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.14. Iran
11.6.14.1. Overview
11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.14.3. Iran Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.14.4. Iran Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.14.5. Iran Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.14.6. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.15. Qatar
11.6.15.1. Overview
11.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.15.3. Qatar Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.15.4. Qatar Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.15.5. Qatar Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.15.6. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11.6.16. Rest of MEA
11.6.16.1. Overview
11.6.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
11.6.16.3. Rest of MEA Market Size and Forecast, By Drug Class, 2020 - 2033 (US$ Million)
11.6.16.4. Rest of MEA Market Size and Forecast, By Treatment Type, 2020 - 2033 (US$ Million)
11.6.16.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
11.6.16.6. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
12. Key Vendor Analysis- Hereditary Angioedema Therapeutics Industry
12.1. Competitive Benchmarking
12.1.1. Competitive Dashboard
12.1.2. Competitive Positioning
12.2. Company Profiles
12.2.1. Takeda Pharmaceutical Company Limited
12.2.2. CSL Behring
12.2.3. Pharming Group N.V.
12.2.4. BioCryst Pharmaceuticals, Inc.
12.2.5. Chiesi Group
12.2.6. Ionis Pharmaceuticals, Inc.
12.2.7. Pharvaris N.V.
12.2.8. Sanofi
12.2.9. Arrowhead Pharmaceuticals, Inc.
12.2.10. Intellia Therapeutics, Inc.
12.2.11. Grifols, S.A.
12.2.12. Octapharma AG
12.2.13. Swedish Orphan Biovitrum (Sobi)
12.2.14. Kedrion Biopharma Inc.
12.2.15. Adverum Biotechnologies, Inc.
12.2.16. Attune Pharmaceuticals, Inc.
12.2.17. BioMarin Pharmaceutical Inc.
12.2.18. Regeneron Pharmaceuticals, Inc.
12.2.19. ADARx Pharmaceuticals, Inc.
12.2.20. Others
13. 360 Degree AnalystView
14. Appendix
14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

• Takeda Pharmaceutical Company Limited
• CSL Behring
• Pharming Group N.V.
• BioCryst Pharmaceuticals, Inc.
• Chiesi Group
• Ionis Pharmaceuticals, Inc.
• Pharvaris N.V.
• Sanofi
• Arrowhead Pharmaceuticals, Inc.
• Intellia Therapeutics, Inc.
• Grifols, S.A.
• Octapharma AG
• Swedish Orphan Biovitrum (Sobi)
• Kedrion Biopharma Inc.
• Adverum Biotechnologies, Inc.
• Attune Pharmaceuticals, Inc.
• BioMarin Pharmaceutical Inc.
• Regeneron Pharmaceuticals, Inc.
• ADARx Pharmaceuticals, Inc.
• Others

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET, BY DRUG CLASS- MARKET ANALYSIS, 2020 - 2033

• C1-Esterase Inhibitors
• Plasma Kallikrein Inhibitors
• Bradykinin B2 Receptor Antagonists
• Factor XIIa Inhibitors
• RNA-Targeted Therapies
• Others

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET, BY TREATMENT TYPE- MARKET ANALYSIS, 2020 - 2033

• On-Demand Treatment
• Prophylaxis Treatment

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020 - 2033

• Intravenous
• Subcutaneous
• Oral

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033

• Hospitals
• Specialty Clinics
• Home Healthcare
• Others

GLOBAL HEREDITARY ANGIOEDEMA THERAPEUTICS MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

North America

• U.S.
• Canada

Europe

• Germany
• UK
• France
• Italy
• Spain
• The Netherlands
• Sweden
• Russia
• Poland
• Denmark
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Thailand
• Philippines
• Taiwan
• Vietnam
• Rest of APAC

Latin America

• Brazil
• Mexico
• Argentina
• Colombia
• Rest of LATAM

The Middle East and Africa

• Saudi Arabia
• UAE
• Israel
• Turkey
• Algeria
• Egypt
• Iran
• Qatar
• Rest of MEA